A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementiaShifu Xiao, Raoli He, Shuzhen Wang et al.|Alzheimer s Research & Therapy|2021Cited by 200
Silencing Livin improved the sensitivity of colon cancer cells to 5-fluorouracil by regulating crosstalk between apoptosis and autophagyShuai Liu, Huijuan Zhu|Oncology Letters|2018Cited by 11